Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/3580
Title: | Biotin-Labelled Clavulanic Acid to Identify Proteins Target for Haptenation in Serum: Implications in Allergy Studies |
Authors: | Martín-Serrano, Ángela Gonzalez-Morena, Juan M. Barbero, Nekane Ariza, Adriana Sánchez Gómez, Francisco J. Pérez-Inestrosa, Ezequiel Pérez-Sala, Dolores Torres, Maria J. Montañez, María I. |
metadata.dc.contributor.authoraffiliation: | [Martín-Serrano,A; Ariza,A; Torres,MJ; Montañez,MI] Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Martín-Serrano.A; Barbero,N; Pérez-Inestrosa,E; Torres,MJ; Montañez,MI] Centro Andaluz de Nanomedicina y Biotecnología-BIONAND, Málaga, Spain. [Gonzalez-Morena,JM] Department of Structural and Chemical Biology, Centro de Investigaciones Biológicas Margarita Salas (CSIC), Madrid, Spain. [Barbero,N; Pérez-Inestrosa,E] Department Química Orgánica, Universidad de Málaga-IBIMA, Málaga, Spain. [Torres,MJ] Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. [Torres,MJ] Department of Medicina, Universidad de Málaga, Málaga, Spain. |
Keywords: | Betalactam;Biotin tag;Biotinylation;Clavulanate;Drug allergy;Haptenation;Beta-lactamas;Biotina;Ácido clavulánico;Hipersensibilidad a las drogas |
metadata.dc.subject.mesh: | Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Biotinylation Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Clavulanic Acids::Clavulanic Acid Medical Subject Headings::Diseases::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions::Drug Hypersensitivity Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoles::Biotin Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Chemistry Techniques, Analytical::Mass Spectrometry Medical Subject Headings::Anatomy::Hemic and Immune Systems::Immune System Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Albumins::Ovalbumin::Avidin Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Globulins::Serum Globulins::Alpha-Globulins::Haptoglobins Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Physicochemical Phenomena::Solubility |
Issue Date: | 18-Nov-2020 |
Publisher: | Frontiers |
Citation: | Martín-Serrano Á, Gonzalez-Morena JM, Barbero N, Ariza A, Sánchez Gómez FJ, Pérez-Inestrosa E, et al. Biotin-Labelled Clavulanic Acid to Identify Proteins Target for Haptenation in Serum: Implications in Allergy Studies. Front Pharmacol. 2020 Nov 18;11:594755 |
Abstract: | Clavulanic acid (CLV) and amoxicillin, frequently administered in combination, can be independently involved in allergic reactions. Protein haptenation with β-lactams is considered necessary to activate the immune system. The aim of this study was to assess the suitability of biotinylated analogues of CLV as probes to study protein haptenation by this β-lactam. Two synthetic approaches afforded the labeling of CLV through esterification of its carboxylic group with a biotin moiety, via either direct binding (CLV-B) or tetraethylenglycol linker (CLV-TEG-B). The second analogue offered advantages as solubility in aqueous solution and potential lower steric hindrance for both intended interactions, with the protein and with avidin. NMR reactivity studies showed that both CLV and CLV-TEG-B reacts through β-lactam ring opening by aliphatic amino nitrogen, however with different stability of resulting conjugates. Unlike CLV conjugates, that promoted the decomposition of clavulanate fragment, the conjugates obtained with the CLV-TEG-B remained linked, as a whole structure including biotin, to nucleophile and showed a better stability. This was a desired key feature to allow CLV-TEG-B conjugated protein detection at great sensitivity. We have used biotin detection and mass spectrometry (MS) to detect the haptenation of human serum albumin (HSA) and human serum proteins. MS of conjugates showed that HSA could be modified by CLV-TEG-B. Remarkably, HSA preincubation with CLV excess only reduced moderately the incorporation of CLV-TEG-B, which could be attributed to different protein interferences. The CLV-TEG-B fragment with opened β-lactam was detected bound to the 404-430HSA peptide of the treated protein. Incubation of human serum with CLV-TEG-B resulted in the haptenation of several proteins that were identified by 2D-electrophoresis and peptide mass fingerprinting as HSA, haptoglobin, and heavy and light chains of immunoglobulins. Taken together, our results show that tagged-CLV keeps some of the CLV features. Moreover, although we observe a different behavior in the conjugate stability and in the site of protein modification, the similar reactivity indicates that it could constitute a valuable tool to identify protein targets for haptenation by CLV with high sensitivity to get insights into the activation of the immune system by CLV and mechanisms involved in β-lactams allergy. |
URI: | http://hdl.handle.net/10668/3580 |
metadata.dc.relation.publisherversion: | https://www.frontiersin.org/articles/10.3389/fphar.2020.594755/full |
metadata.dc.identifier.doi: | 10.3389/fphar.2020.594755 |
ISSN: | 1663-9812 (Online) |
Appears in Collections: | 01- Artículos - BIONAND - Centro Andaluz de Nanomedicina y Biotecnología 01- Artículos - Hospital Regional de Málaga 01- Artículos - IBIMA. Instituto de Investigación Biomédica de Málaga |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MartinSerrano_BiotinLabelled.pdf | Artículo publicado | 1,98 MB | Adobe PDF | View/Open |
MartinSerrano_BiotinLabelled_MaterialSuplementario.pdf | Material suplementario | 1,86 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License